Drug Interaction between Acenocoumarol and Linezolid. 2017

Kinjalka Ghosh, and Kanjaksha Ghosh
Assistant Professor of Biochemistry, KEM Hospital, Mumbai, Maharashtra.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D004347 Drug Interactions The action of a drug that may affect the activity, metabolism, or toxicity of another drug. Drug Interaction,Interaction, Drug,Interactions, Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000069349 Linezolid An oxazolidinone and acetamide derived ANTI-BACTERIAL AGENT and PROTEIN SYNTHESIS INHIBITOR that is used in the treatment of GRAM-POSITIVE BACTERIAL INFECTIONS of the skin and respiratory tract. Linezolide,N-((3-(3-fluoro-4-morpholinylphenyl)-2-oxo-5-oxazolidinyl)methyl)acetamide,PNU-100766,U 100766,U-100766,Zyvox,100766, U,PNU 100766,PNU100766,U100766
D000074 Acenocoumarol A coumarin that is used as an anticoagulant. Its actions and uses are similar to those of WARFARIN. (From Martindale, The Extra Pharmacopoeia, 30th ed, p233) Acenocoumarin,Nicoumalone,Mini-Sintrom,Sinkumar,Sinthrome,Sintrom,Syncoumar,Syncumar,Synthrom,Mini Sintrom,MiniSintrom
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D000925 Anticoagulants Agents that prevent BLOOD CLOTTING. Anticoagulant Agent,Anticoagulant Drug,Anticoagulant,Anticoagulant Agents,Anticoagulant Drugs,Anticoagulation Agents,Indirect Thrombin Inhibitors,Agent, Anticoagulant,Agents, Anticoagulant,Agents, Anticoagulation,Drug, Anticoagulant,Drugs, Anticoagulant,Inhibitors, Indirect Thrombin,Thrombin Inhibitors, Indirect
D019934 International Normalized Ratio System established by the World Health Organization and the International Committee on Thrombosis and Hemostasis for monitoring and reporting blood coagulation tests. Under this system, results are standardized using the International Sensitivity Index for the particular test reagent/instrument combination used. INR,International Normalized Ratios,Normalized Ratio, International,Normalized Ratios, International,Ratio, International Normalized,Ratios, International Normalized

Related Publications

Kinjalka Ghosh, and Kanjaksha Ghosh
July 2016, The Journal of the Association of Physicians of India,
Kinjalka Ghosh, and Kanjaksha Ghosh
January 2024, Cureus,
Kinjalka Ghosh, and Kanjaksha Ghosh
January 2015, Internal medicine (Tokyo, Japan),
Kinjalka Ghosh, and Kanjaksha Ghosh
January 1995, Presse medicale (Paris, France : 1983),
Kinjalka Ghosh, and Kanjaksha Ghosh
December 2012, European journal of clinical pharmacology,
Kinjalka Ghosh, and Kanjaksha Ghosh
March 2013, European journal of clinical pharmacology,
Kinjalka Ghosh, and Kanjaksha Ghosh
January 1997, The Annals of pharmacotherapy,
Kinjalka Ghosh, and Kanjaksha Ghosh
June 1996, British journal of clinical pharmacology,
Kinjalka Ghosh, and Kanjaksha Ghosh
January 2011, Antiviral therapy,
Kinjalka Ghosh, and Kanjaksha Ghosh
February 2002, The Annals of pharmacotherapy,
Copied contents to your clipboard!